摘要
本研究应用纯系大鼠(Lou→F344)心脏移植模型,比较分析了CsA和不同剂量T4治疗组的移植心脏存活时间、病理损害计分以及移植受体大鼠脾单个核细胞IL-2生成活性和血清sIL-2R水平,证实T4可明显延长移植心脏存活时间和减少移植排异反应程度。此研究结果表明T4具有较强的抗移植排异作用。
In order to confirm the anti-rejection effect of Tripcholorolide(T4),we compared the mean survival time of cardiac allograft,scores of pathological damage of the heart,the generation of IL-2 from splenocytes stimulated by ConA,and the serum level of slL-2R in the heart transplant model(Lou→F344)that received either cyclosporine or T4.The present study has shown that T4 could prolong the MST of cardiac allograft and significantly decrease the degrees of pathological damage of the transplant heart.The results indicated that T4 might be used as new anti-rejection drug in organ transplantation.
出处
《中国医学科学院学报》
CAS
CSCD
北大核心
1994年第6期438-442,共5页
Acta Academiae Medicinae Sinicae
基金
卫生部自然科学基金